These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21970087)

  • 1. Syncope with cholinesterase inhibitors.
    Prescrire Int; 2011 Oct; 20(120):240. PubMed ID: 21970087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
    Gill SS; Anderson GM; Fischer HD; Bell CM; Li P; Normand SL; Rochon PA
    Arch Intern Med; 2009 May; 169(9):867-73. PubMed ID: 19433698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events in patients receiving cholinesterase inhibitors due to dissimilar follow-up periods.
    Chan M
    Arch Intern Med; 2009 Oct; 169(18):1724; author reply 1724-5. PubMed ID: 19822833
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
    Hernandez RK; Farwell W; Cantor MD; Lawler EV
    J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
    Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety].
    Richard E; van Gool WA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):530-2. PubMed ID: 16566413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.
    Paulison B; Léos CL
    Cardiovasc Toxicol; 2010 Dec; 10(4):306-10. PubMed ID: 20865460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases.
    Osmonov D; Özcan KS; Erdinler I; Altay S; Turkkan C; Yildirim E; Gurkan K
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):311-4. PubMed ID: 22815079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil: syncope. Various cardiac disorders.
    Prescrire Int; 2008 Jun; 17(95):113. PubMed ID: 18630357
    [No Abstract]   [Full Text] [Related]  

  • 14. Donepezil and cardiac syncope: case report.
    Jane Newby V; Anne Kenny R; McKeith IG
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1110-2. PubMed ID: 15497193
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivastigmine for dementia associated with Parkinson's disease.
    Emre M; Aarsland D; Albanese A; Byrne EJ; Deuschl G; De Deyn PP; Durif F; Kulisevsky J; van Laar T; Lees A; Poewe W; Robillard A; Rosa MM; Wolters E; Quarg P; Tekin S; Lane R
    N Engl J Med; 2004 Dec; 351(24):2509-18. PubMed ID: 15590953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
    Antuono PG
    Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.
    Ng B
    Ann Intern Med; 2011 Nov; 155(10):JC5-10. PubMed ID: 22084357
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease.
    Isik AT; Bozoglu E; Naharci MI; Kilic S
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):454-9. PubMed ID: 21335298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxysmal atrioventricular block due to anticholinesterase therapy].
    Brembilla-Perrot B; Regent MC; Hanesse B; Maheut-Bosser A; Schmal Laurain MC; Lemoine J; Popovic B; Tréchot P
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1265-7. PubMed ID: 15669371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.